Table 2 Characterization of MRSA isolates
Patient | Sample | SCCmec | MLST | PVL | Antibiotic resistance pattern |
|---|---|---|---|---|---|
A | Pharyngeal | Type IV | ST146 (CC5) | Negative | Resistance to: erythromycin, clindamycin, tobramycin and ciprofloxacin |
B | Nasal and Pharyngeal | Type IV | ST125 (CC5) | Negative | Resistance to: erythromycin, tobramycin and ciprofloxacin |
C | Nasal | NA | NA | Negative | Resistance to: erythromycin, tobramycin and ciprofloxacin |